T. Rowe Price Health Sciences (PRHSX)
* As of 30-Apr-15
Quotes delayed, except where indicated otherwise. Currency in USD.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||0.77%|
Performance & Risk
|5y Avg Return:||28.52%|
|Rank in Category (ytd):||7|
|% Rank in Category (ytd):||5.34%|
|Morningstar Risk Rating:||4|
The investment seeks long-term capital appreciation.
The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. View More